Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.67 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8756338 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL15754645 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL15754583 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL117794 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL15754680 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL9469998 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL74736 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL5244402 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL713149 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 | |
| SCHEMBL9470356 | 1.00 | FAAH (0.67) | FAAHDNM1CASP2NAAAHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 973 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189643-A1 | FIREFIGHTING FOAM COMPOSITION | TYCO FIRE PRODUCTS LP (US) | 2024-06-13 | — | — | US | claimed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2024091736-A2 | LONG WEAR NON-CRACKING COLOR COSMETIC COMPOSITIONS | REVLON CONSUMER PRODUCTS LLC (US) | 2024-05-02 | — | — | WO | claimed |
| US-11951345-B2 | Firefighting foam composition | TYCO FIRE PRODUCTS LP (US) | 2024-04-09 | — | — | US | claimed |
| EP-4337344-A1 | FIREFIGHTING FOAM COMPOSITION | Tyco Fire Products LP (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4337340-A1 | FIRE-FIGHTING FOAM CONCENTRATE | Tyco Fire Products LP (US) | 2024-03-20 | — | — | EP | claimed |
| US-11911644-B2 | Fire-fighting foam concentrate | TYCO FIRE PRODUCTS LP (US) | 2024-02-27 | — | — | US | claimed |
| EP-3836980-B1 | FORMULATION | OCUTEC LTD (GB) | 2024-02-14 | — | — | EP | claimed |
| US-11890496-B2 | Firefighting foam composition | TYCO FIRE PRODUCTS LP (US) | 2024-02-06 | — | — | US | claimed |
| US-11766304-B2 | Sterile surgical drape for use with a C-arm x-ray machine | DAVIS MARTIN (US) | 2023-09-26 | — | — | US | claimed |
| US-20020064510-A1 | Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds | GOLDSCHMIDT CHEMICAL CORPORATION (US) | 2002-05-30 | — | — | US | claimed |
| US-6376455-B1 | FABRIC SOFTENER, QUATERNARY FATTY ACID AMINO ALCOHOL ESTERS OF METHYLETHANOLISOPROPANOLAMINE (MEIPA) WITH FATTY ACIDS IN THE RATIO OF FROM 1:1.5 TO 1:2 WITH USE OF MONOFUNCTIONAL ALCOHOLS OR BIFUNCTIONAL ALCOHOLS. | GOLDSCHMIDT REWO GMBH & CO. KG (DE) | 2002-04-23 | — | — | US | claimed |
| US-6329353-B1 | Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds | GOLDSCHMIDT CHEMICAL CORPORATION | 2001-12-11 | — | — | US | claimed |
| US-6211139-B1 | Polyester polyquaternary compounds, compositions containing them, and use thereof | GOLDSCHMIDT CHEMICAL CORPORATION | 2001-04-03 | — | — | US | claimed |
| EP-1076554-A1 | CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS | Goldschmidt Chemical Company (US) | 2001-02-21 | — | — | EP | claimed |
| EP-1045891-A1 | NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF | Goldschmidt Chemical Corporation (US) | 2000-10-25 | — | — | EP | claimed |
| WO-1999058106-A1 | CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS | GOLDSCHMIDT CHEMICAL COMPANY (US) | 1999-11-18 | — | — | WO | claimed |
| WO-1999035223-A1 | NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF | WITCO CORPORATION (US) | 1999-07-15 | — | — | WO | claimed |
| WO-1999035120-A1 | NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF | WITCO CORPORATION (US) | 1999-07-15 | — | — | WO | claimed |
| EP-0316618-B1 | Multilayer flat light sensitive registration material | BASF AG (DE) | 1994-08-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020064510-A1 | Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds | POLR1C, NUP50, ARG1 | FAAH 1774/4885DNM1 1455/4885CASP2 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.